Ebola Trial
- All
- News
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
2 Experimental Drugs "Very Good News" For Ebola Treatment: Scientists
Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed encouraging survival results in a clinical trial in Congo.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
New Ebola Vaccine Safe, Stimulates Strong Immune Response
A fresh clinical trial of a new Ebola vaccine has found that it is well tolerated, safe and stimulates strong immune responses in adults in Mali, West Africa and in the US.
-
China-Made Ebola Vaccine Permitted for Overseas Trial
A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
Vaccine Offers 100% Ebola Protection: Trial Results
An Ebola vaccine provided 100-percent protection in a field trial in hard-hit Guinea, researchers and officials said Friday, mooting "the beginning of the end" of the killer West African outbreak.
-
Needle-Free, Inhalable Vaccine Developed for Ebola
The first needle-free Ebola vaccine that can be inhaled protects non-human primates against the deadly virus and may advance to human clinical trials soon, scientists say.
-
Ghana Halts Ebola Vaccine Trial Due to Community Protests
Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday.
-
Indian-Origin Researcher Helps in Ebola Vaccine Trials
An Indian-origin researcher has helped in identifying the kind of human trial that is most effective for testing Ebola vaccines so as to stop future outbreaks of the deadly virus.
-
Ebola Vaccine Trial Begins in Sierra Leone
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
Guinea to Start Final Trials of Ebola Vaccines This Week
Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.
-
Ebola Drug in Guinea Helps Some, Stirs Debate on Broader Use
A Japanese anti-Ebola drug being tested in Guinea should be made available across West Africa after initial trials showed it halved mortality rates in some patients, the medical charity administering it said.
-
Limited Promise in Early Results from Ebola Drug Trial
Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed on Monday that it was somewhat effective at saving lives if given early in the illness, but not later.
-
Marburg Virus Outbreak in Rwanda: Spread, Symptoms, and Global Concerns
Rwanda's first Marburg virus outbreak has resulted in 11 deaths. Health officials are responding with clinical trials to address the spread. The virus, related to Ebola, can cause severe haemorrhagic fever and is often linked to fruit bats.
-
2 Experimental Drugs "Very Good News" For Ebola Treatment: Scientists
Scientists are a step closer to finding the first effective treatments for the deadly Ebola haemorrhagic fever after two potential drugs showed encouraging survival results in a clinical trial in Congo.
-
New Testing Of Ebola Vaccine To Start Next Month In Canada
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
-
New Ebola Vaccine Safe, Stimulates Strong Immune Response
A fresh clinical trial of a new Ebola vaccine has found that it is well tolerated, safe and stimulates strong immune responses in adults in Mali, West Africa and in the US.
-
China-Made Ebola Vaccine Permitted for Overseas Trial
A restructured Ebola vaccine independently developed by China has entered phase two clinical trials in Sierra Leone, marking the vaccine's first overseas clinical trial permit.
-
Ebola Vaccine Found Safe, Effective in Monkeys
A single dose of an experimental Ebola virus (EBOV) vaccine, currently undergoing testing in humans, completely protects monkeys against the current outbreak strain, when given at least seven days before exposure, scientists have found.
-
Vaccine Offers 100% Ebola Protection: Trial Results
An Ebola vaccine provided 100-percent protection in a field trial in hard-hit Guinea, researchers and officials said Friday, mooting "the beginning of the end" of the killer West African outbreak.
-
Needle-Free, Inhalable Vaccine Developed for Ebola
The first needle-free Ebola vaccine that can be inhaled protects non-human primates against the deadly virus and may advance to human clinical trials soon, scientists say.
-
Ghana Halts Ebola Vaccine Trial Due to Community Protests
Ghana has halted a plan to test two Ebola vaccines in an eastern town after legislators backed local protests against the trials sparked by fears of contamination, officials said on Wednesday.
-
Indian-Origin Researcher Helps in Ebola Vaccine Trials
An Indian-origin researcher has helped in identifying the kind of human trial that is most effective for testing Ebola vaccines so as to stop future outbreaks of the deadly virus.
-
Ebola Vaccine Trial Begins in Sierra Leone
Thousands of healthcare workers in areas of Sierra Leone that are grappling with Ebola will now begin receiving an experimental vaccine against the often deadly virus, officials said Tuesday.
-
2 Experimental Ebola Vaccines Appear Safe Says United States Agency
Two experimental Ebola vaccines, tested in Liberia on more than 600 people in a phase 2 clinical trial appear to be safe, the US National Institute of Allergy and Infectious Diseases (NIAID) said Thursday.
-
Guinea to Start Final Trials of Ebola Vaccines This Week
Final stage trials of an Ebola vaccine being developed by Merck and NewLink Genetics will begin in Guinea on March 7, the World Health Organization said today.
-
Ebola Drug in Guinea Helps Some, Stirs Debate on Broader Use
A Japanese anti-Ebola drug being tested in Guinea should be made available across West Africa after initial trials showed it halved mortality rates in some patients, the medical charity administering it said.
-
Limited Promise in Early Results from Ebola Drug Trial
Early results from an Ebola trial using the experimental drug Avigan (favipiravir) showed on Monday that it was somewhat effective at saving lives if given early in the illness, but not later.
